Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

163 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Isolated ocular flutter.
Nasu S, Uzawa A, Mori M, Kuwabara S. Nasu S, et al. Neurology. 2013 Feb 26;80(9):867. doi: 10.1212/WNL.0b013e31828407a8. Neurology. 2013. PMID: 23439702 No abstract available.
Neuromuscular transmission is not impaired in axonal Guillain--Barré syndrome.
Kuwabara S, Kokubun N, Misawa S, Kanai K, Isose S, Shibuya K, Noto Y, Mori M, Sekiguchi Y, Nasu S, Fujimaki Y, Hirata K, Yuki N. Kuwabara S, et al. Among authors: nasu s. J Neurol Neurosurg Psychiatry. 2011 Oct;82(10):1174-7. doi: 10.1136/jnnp.2010.210708. Epub 2010 Nov 11. J Neurol Neurosurg Psychiatry. 2011. PMID: 21071752
Elevated CSF TDP-43 levels in amyotrophic lateral sclerosis: specificity, sensitivity, and a possible prognostic value.
Noto Y, Shibuya K, Sato Y, Kanai K, Misawa S, Sawai S, Mori M, Uchiyama T, Isose S, Nasu S, Sekiguchi Y, Fujimaki Y, Kasai T, Tokuda T, Nakagawa M, Kuwabara S. Noto Y, et al. Among authors: nasu s. Amyotroph Lateral Scler. 2011 Mar;12(2):140-3. doi: 10.3109/17482968.2010.541263. Epub 2010 Dec 2. Amyotroph Lateral Scler. 2011. PMID: 21126161
Markedly reduced axonal potassium channel expression in human sporadic amyotrophic lateral sclerosis: an immunohistochemical study.
Shibuya K, Misawa S, Arai K, Nakata M, Kanai K, Yoshiyama Y, Ito K, Isose S, Noto Y, Nasu S, Sekiguchi Y, Fujimaki Y, Ohmori S, Kitamura H, Sato Y, Kuwabara S. Shibuya K, et al. Among authors: nasu s. Exp Neurol. 2011 Dec;232(2):149-53. doi: 10.1016/j.expneurol.2011.08.015. Epub 2011 Aug 30. Exp Neurol. 2011. PMID: 21906595
Markedly upregulated serum interleukin-12 as a novel biomarker in POEMS syndrome.
Kanai K, Sawai S, Sogawa K, Mori M, Misawa S, Shibuya K, Isose S, Fujimaki Y, Noto Y, Sekiguchi Y, Nasu S, Nakaseko C, Takano S, Yoshitomi H, Miyazaki M, Nomura F, Kuwabara S. Kanai K, et al. Among authors: nasu s. Neurology. 2012 Aug 7;79(6):575-82. doi: 10.1212/WNL.0b013e318263c42b. Epub 2012 Jul 25. Neurology. 2012. PMID: 22843279
Ambiguous effects of anti-VEGF monoclonal antibody (bevacizumab) for POEMS syndrome.
Sekiguchi Y, Misawa S, Shibuya K, Nasu S, Mitsuma S, Iwai Y, Beppu M, Sawai S, Ito S, Hirano S, Nakaseko C, Kuwabara S. Sekiguchi Y, et al. Among authors: nasu s. J Neurol Neurosurg Psychiatry. 2013 Dec;84(12):1346-8. doi: 10.1136/jnnp-2012-304874. Epub 2013 Mar 5. J Neurol Neurosurg Psychiatry. 2013. PMID: 23463868
163 results